Format

Send to

Choose Destination
Hippokratia. 2008;12(4):198-204.

S100 protein family and its application in clinical practice.

Author information

1
Neurology Department, Aristotelian University of Thessaloniki, AHEPA General Hospital, Thessaloniki, Greece.

Abstract

The members of the S100 protein family are multifunctional proteins with a regulatory role in a variety of cellular processes. They exert their actions usually through calcium binding, although Zn2+ and Cu2+ have also been shown to regulate their biological activity. The most studied member, protein S100B, exhibits neurotrophic (at physiologic concentration) or neurotoxic (at higher concentration) activity and its immunohistochemical expression or serum levels have been determined in various clinical disorders. S100B has been well documented as a marker of astrocytic activation mediating its effects via interaction with receptor for advanced glycation end products (RAGE). We herein provide a wide range of information concerning their clinical application in traumatic brain injuries, Alzheimer disease, subarachnoid haemorrhage and other neurologic disorders, malignant melanoma and several other neoplasms (as S100B has been shown to down-regulate p53), as well as inflammatory diseases. Also its use on predicting neurologic outcome after resuscitation for cardiac arrest or in intrauterine growth retardation newborns is discussed.

KEYWORDS:

S100 protein family; malignant melanoma; neurodegenerative disorders; protein S100B; traumatic brain injury

PMID:
19158963
PMCID:
PMC2580040

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center